Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
AIM | AIM ImmunoTech Inc. | Chief Financial Officer | Apr 4, 2022 | |||
AGGX | AngioGenex, Inc. | Director, INDEPENDENT DIRECTOR | Dec 31, 2021 | |||
ENVB | Enveric Biosciences, Inc. | Chief Financial Officer | Sep 9, 2022 | |||
NVTA | Invitae Corp | Interim Chief Financial Officer Exhibit List: Exhibit 24 - Power of Attorney | Aug 14, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|